Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells

References

• Mathema VB, Na-Bangchang K. Current insights on cholangiocarcinoma research: a brief review. Asian Pac J Cancer Prev. 2015;16(4):1307–13. doi:10.7314/apjcp.2015.16.4.1307. PMID: 25743790.
   PubMedGoogle Scholar
• Zabron A, Edwards RJ, Khan SA. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech. 2013;6(2):281–92. doi:10.1242/dmm.010561. PMID: 23520144.
   PubMed Web of Science ®Google Scholar
• Gatto M, Alvaro D. Cholangiocarcinoma: risk factors and clinical presentation. Eur Rev Med Pharmacol Sci. 2010;14(4):363–67. PMID: 20496549.
   PubMed Web of Science ®Google Scholar
• Yu Y, Cui J. Present and future of cancer immunotherapy: A tumor microenvironmental perspective. Oncol Lett. 2018;16(4):4105–13. doi:10.3892/ol.2018.9219. PMID: 30214551.
   PubMed Web of Science ®Google Scholar
• Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235–71. doi:10.1146/annurev-immunol-031210-101324. PMID: 21219185.
   PubMed Web of Science ®Google Scholar
• Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, Grosse-Wilde H, Broelsch CE, Gerken G, Cicinnati VR. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res. 2004;10(21):7260–69. doi:10.1158/1078-0432.CCR-04-0872. PMID: 15534100.
   PubMed Web of Science ®Google Scholar
• Huang A, Gilmour JW, Imami N, Amjadi P, Henderson DC, Allen-Mersh TG. Increased serum transforming growth factor-β1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration. Clin Exp Immunol. 2003;134(2):270–78. doi:10.1046/j.1365-2249.2003.02295.x. PMID: 14616787.
   PubMed Web of Science ®Google Scholar
• Lim DS, Kim JH, Lee DS, Yoon CH, Bae YS. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors. Cancer Immunol Immunother. 2007;56(11):1817–29. doi:10.1007/s00262-007-0325-0. PMID: 17443323.
   PubMed Web of Science ®Google Scholar
• Hasita H, Komohara Y, Okabe H, Masuda T, Ohnishi K, Lei XF, Beppu T, Baba H, Takeya M. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. Cancer Sci. 2010;101(8):1913–19. doi:10.1111/j.1349-7006.2010.01614.x. PMID: 20545696.
   PubMed Web of Science ®Google Scholar
• Ahn YH, Hong SO, Kim JH, Noh KH, Song KH, Lee YH, Jeon JH, Kim DW, Seo JH, Kim TW. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-beta receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity. Clin Exp Immunol. 2015;181(1):164–78. doi: 10.1111/cei.12620. PMID: 25753156.
   PubMed Web of Science ®Google Scholar
• Thepmalee C, Panya A, Junking M, Chieochansin T, Yenchitsomanus PT. Inhibition of IL-10 and TGF-beta receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells. Hum Vaccin Immunother. 2018;14(6):1423–31. doi:10.1080/21645515.2018.1431598. PMID: 29420117.
   PubMed Web of Science ®Google Scholar
• Sundarasetty BS, Chan L, Darling D, Giunti G, Farzaneh F, Schenck F, Naundorf S, Kuehlcke K, Ruggiero E, Schmidt M, et al. Lentivirus-induced ‘Smart’ dendritic cells: pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma. Gene Ther. 2015;22(9):707–20. doi:10.1038/gt.2015.43. PMID: 25965393.
   PubMed Web of Science ®Google Scholar
• Panya A, Thepmalee C, Sawasdee N, Sujjitjoon J, Phanthaphol N, Junking M, Wongkham S, Yenchitsomanus PT. Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells. Cancer Immunol Immunother. 2018. doi:10.1007/s00262-018-2212-2. PMID: 30056600.
   PubMed Web of Science ®Google Scholar
• Ni K, O’Neill HC. The role of dendritic cells in T cell activation. Immunol Cell Biol. 1997;75(3):223–30. doi:10.1038/icb.1997.35. PMID: 9243286.
   PubMed Web of Science ®Google Scholar
• Yamanaka R, Abe T, Yajima N, Tsuchiya N, Homma J, Kobayashi T, Narita M, Takahashi M, Tanaka R. Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer. 2003;89(7):1172–79. doi:10.1038/sj.bjc.6601268. PMID: 14520441.
   PubMed Web of Science ®Google Scholar
• Morris SC, Heidorn SM, Herbert DBR, Perkins C, Hildeman DA, Khodoun MV, Finkelman FD. Endogenously produced IL-4 nonredundantly stimulates CD8(+) T cell proliferation. J Immunol. 2009;182(3):1429–38. doi:10.4049/jimmunol.182.3.1429. PMID: 19155490.
   PubMed Web of Science ®Google Scholar
• Silva-Filho JL, Caruso-Neves C, Pinheiro AAS. IL-4: an important cytokine in determining the fate of T cells. Biophys Rev. 2014;6(1):111–18. doi:10.1007/s12551-013-0133-z. PMID: 28509961.
   PubMedGoogle Scholar
• Wada H, Noguchi Y, Marino MW, Dunn AR, Old LJ. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc Natl Acad Sci U S A. 1997;94(23):12557–61. doi:10.1073/pnas.94.23.12557. PMID: 9356488.
   PubMed Web of Science ®Google Scholar
• Junking M, Grainok J, Thepmalee C, Wongkham S, Yenchitsomanus PT. Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA. Tumour Biol. 2017;39(10):1010428317733367. doi:10.1177/1010428317733367. PMID: 29034817.
   Google Scholar